401 related articles for article (PubMed ID: 25237062)
1. An impedance-based cellular assay using human iPSC-derived cardiomyocytes to quantify modulators of cardiac contractility.
Scott CW; Zhang X; Abi-Gerges N; Lamore SD; Abassi YA; Peters MF
Toxicol Sci; 2014 Dec; 142(2):331-8. PubMed ID: 25237062
[TBL] [Abstract][Full Text] [Related]
2. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
Himmel HM
J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
[TBL] [Abstract][Full Text] [Related]
4. Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.
Wei F; Pourrier M; Strauss DG; Stockbridge N; Pang L
Toxicol Sci; 2020 Apr; 174(2):254-265. PubMed ID: 32040191
[TBL] [Abstract][Full Text] [Related]
5. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
Yang X; Papoian T
J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
[TBL] [Abstract][Full Text] [Related]
6. Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity.
Sharma A; McKeithan WL; Serrano R; Kitani T; Burridge PW; Del Álamo JC; Mercola M; Wu JC
Nat Protoc; 2018 Dec; 13(12):3018-3041. PubMed ID: 30413796
[TBL] [Abstract][Full Text] [Related]
7. Integration of mechanical conditioning into a high throughput contractility assay for cardiac safety assessment.
Goßmann M; Linder P; Thomas U; Juhasz K; Lemme M; George M; Fertig N; Dragicevic E; Stoelzle-Feix S
J Pharmacol Toxicol Methods; 2020 Sep; 105():106892. PubMed ID: 32629160
[TBL] [Abstract][Full Text] [Related]
8. SarcTrack.
Toepfer CN; Sharma A; Cicconet M; Garfinkel AC; Mücke M; Neyazi M; Willcox JAL; Agarwal R; Schmid M; Rao J; Ewoldt J; Pourquié O; Chopra A; Chen CS; Seidman JG; Seidman CE
Circ Res; 2019 Apr; 124(8):1172-1183. PubMed ID: 30700234
[TBL] [Abstract][Full Text] [Related]
9. Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes.
Jonsson MK; Wang QD; Becker B
Assay Drug Dev Technol; 2011 Dec; 9(6):589-99. PubMed ID: 22085047
[TBL] [Abstract][Full Text] [Related]
10. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
[TBL] [Abstract][Full Text] [Related]
11. Video-based assessment of drug-induced effects on contractile motion properties using human induced pluripotent stem cell-derived cardiomyocytes.
Okai Y; Matsune K; Yamanaka K; Matsui T; Pfeiffer Kaushik E; Harada K; Kohara H; Miyawaki A; Ozaki H; Wagoner M; Shinozawa T
J Pharmacol Toxicol Methods; 2020 Sep; 105():106893. PubMed ID: 32619502
[TBL] [Abstract][Full Text] [Related]
12. Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System.
Xi B; Wang T; Li N; Ouyang W; Zhang W; Wu J; Xu X; Wang X; Abassi YA
J Lab Autom; 2011 Dec; 16(6):415-21. PubMed ID: 22093298
[TBL] [Abstract][Full Text] [Related]
13. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
14. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.
Navarrete EG; Liang P; Lan F; Sanchez-Freire V; Simmons C; Gong T; Sharma A; Burridge PW; Patlolla B; Lee AS; Wu H; Beygui RE; Wu SM; Robbins RC; Bers DM; Wu JC
Circulation; 2013 Sep; 128(11 Suppl 1):S3-13. PubMed ID: 24030418
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications.
Peters MF; Scott CW; Ochalski R; Dragan YP
Assay Drug Dev Technol; 2012 Dec; 10(6):525-32. PubMed ID: 22574652
[TBL] [Abstract][Full Text] [Related]
16. The Use of Voltage Sensitive Dye di-4-ANEPPS and Video-Based Contractility Measurements to Assess Drug Effects on Excitation-Contraction Coupling in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Hortigon-Vinagre MP; Zamora V; Burton FL; Smith GL
J Cardiovasc Pharmacol; 2021 Mar; 77(3):280-290. PubMed ID: 33109927
[TBL] [Abstract][Full Text] [Related]
17. Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance.
Satsuka A; Hayashi S; Yanagida S; Ono A; Kanda Y
J Pharmacol Toxicol Methods; 2022; 118():107227. PubMed ID: 36243255
[TBL] [Abstract][Full Text] [Related]
18. Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.
Peters MF; Lamore SD; Guo L; Scott CW; Kolaja KL
Cardiovasc Toxicol; 2015 Apr; 15(2):127-39. PubMed ID: 25134468
[TBL] [Abstract][Full Text] [Related]
19. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Rampoldi A; Singh M; Wu Q; Duan M; Jha R; Maxwell JT; Bradner JM; Zhang X; Saraf A; Miller GW; Gibson G; Brown LA; Xu C
Toxicol Sci; 2019 May; 169(1):280-292. PubMed ID: 31059573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]